Similar Papers

Paper Title
Journal
Date
Author
How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
Myron Schwartz ... Josep Llovet
Journal of Hepatology | VOL. 43
Myron Schwartz, et. al.Myron Schwartz ... Josep Llovet
02 Aug 2005
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Toshifumi Tada ...
Hepatology Research | VOL. 50
Toshifumi Tada, et. al.Toshifumi Tada ...
06 Dec 2019
Surgical resection for recurrent hepatocellular carcinoma: Prognosis and analysis of risk factors
Rey-Heng Hu ... Ding-Shinn Chen
Surgery | VOL. 120
Rey-Heng Hu, et. al.Rey-Heng Hu ... Ding-Shinn Chen
01 Jul 1996
A case of complete response with rechallenge-lenvatinib plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma refractory to multiple molecular-targeted agent treatments.
Tetsu Tomonari ... Yasushi Sato
Clinical journal of gastroenterology | VOL. 16
Tetsu Tomonari, et. al.Tetsu Tomonari ... Yasushi Sato
01 Mar 2023
View more papers

More From: Hepatology Research

Paper Title
Journal
Date
Author
Impact of the revised Japanese indication criteria for deceased donor liver transplantation on liver cirrhotic patients of Child–Pugh classification B with hepatocellular carcinoma
Akihiro Seki ... Taro Yamashita
Hepatology Research | VOL. -
Akihiro Seki, et. al.Akihiro Seki ... Taro Yamashita
09 Feb 2025
Correction to “Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression”
-
Hepatology Research | VOL. -
--
04 Feb 2025
Correction to “Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA”
-
Hepatology Research | VOL. -
--
04 Feb 2025
Issue Information
-
Hepatology Research | VOL. 55
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.